LCG
LLY icon

Lakeshore Capital Group’s Eli Lilly LLY Stock Holding History

Lakeshore Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
1,046
-13
-1% -$13.3K 0.93% 34
2026
Q1 		$974K Buy
1,059
+7
+0.7% +$7.1K 0.8% 42
2025
Q4 		$1.13M Buy
1,052
+2
+0.2% +$1.91K 0.9% 33
2025
Q3 		$801K Buy
1,050
+20
+2% +$14.9K 0.65% 45
2025
Q2 		$803K Buy
1,030
+5
+0.5% +$3.88K 0.71% 43
2025
Q1 		$847K Buy
1,025
+15
+1% +$12.5K 0.82% 40
2024
Q4 		$779K Buy
+1,010
New +$836K 1.18% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lakeshore Capital Group's LLY Position: Q2 2026 in Review

Lakeshore Capital Group reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $13.3K and leaving 1,046 shares worth $1.25M. The position accounts for 0.93% of the portfolio, ranked #34.

Lakeshore Capital Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lakeshore Capital Group held 1,046 shares of Eli Lilly worth $1.25M as of Q2 2026.
  • Lakeshore Capital Group sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.93% of Lakeshore Capital Group's portfolio in Q2 2026, its #34 holding.
  • Lakeshore Capital Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lakeshore Capital Group's 13F filing for Q2 2026, filed 31 Jul 2026.